Jens Lundgren

42PUBLICATIONS
262CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityImmunogenetics (incl. genetic immunology)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Oct 10, 2026
Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study.

|Sep 02, 2026
Factors Associated with Persistently Increased IL-6 Levels in People with HIV.

|Aug 18, 2026
Cardiovascular Disease Risk with Integrase Inhibitor-based Antiretroviral Therapy: A Causal Inference Analysis in RESPOND.

|Jun 25, 2026
Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials.

|May 30, 2026
Early high-resolution immune profiles are associated with survival, relapse and graft-versus-host-disease after allogeneic hematopoietic cell transplantation.

|Apr 22, 2026
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial.

Pageof 7

Frequent Collaborators

8 joint publications

Sisse Rye Ostrowski

7 joint publications

Joanne Reekie

6 joint publications

Michael Perch

6 joint publications

Thomas Benfield